BANGALORE, Dec 1 (Reuters) - Biotechnology company Alkermes Inc said its collaboration with Cephalon Inc on Vivitrol, a treatment for alcohol dependence, was terminated, and raised its 2009 earnings view to reflect revenue and expenses from Vivitrol.
